Research Article

Olfactory Neuroblastomas: An Experience of 24 Years

Table 3

Treatment modalities.

Patient no.Surgical procedureCTXDuration of CTX (Months)Total radiotherapy fraction (Gy)

1Craniofacial resection 50
2cisplatin + etoposid 8 56
3Craniofacial resection 65
4cisplatin + etoposid ndoxan + vincristin + doxorubicin12 65
5 60
6Craniofacial resection 50
7 60
8Maxillectomi + Orbital exenteration 50
9Craniofacial resection 36
10 66
11Craniofacia resectioncisplatin + etoposid 5 60
12Craniofacial resectioncisplatin + etoposid 5 56
13External thmoidectomycisplatin + etoposid cisplatin + vinkristin 10 60
14cisplatin + etoposid carboplatin + etoposid 7
15Craniofacial resection
16Craniofacial resection
17Craniofacial resectionCisplatin 1 70
18Nasal resection
19Nasal resection 54